Targeting Resistance against the MDM2 Inhibitor RG7388 in Glioblastoma Cells by the MEK Inhibitor Trametinib

Title
Targeting Resistance against the MDM2 Inhibitor RG7388 in Glioblastoma Cells by the MEK Inhibitor Trametinib
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 25, Issue 1, Pages 253-265
Publisher
American Association for Cancer Research (AACR)
Online
2018-10-01
DOI
10.1158/1078-0432.ccr-18-1580

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation